home / openregs

documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

47 rows where docket_id = "FDA-2000-P-0133" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: subtype, posted_date, posted_month, comment_start_date, comment_end_date, open_for_comment, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

posted_year 7

  • 2011 27
  • 2010 10
  • 2020 4
  • 2000 3
  • 2001 1
  • 2003 1
  • 2012 1

document_type 4

  • Supporting & Related Material 21
  • Other 18
  • Notice 5
  • Proposed Rule 3

agency_id 1

  • FDA 47
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2000-P-0133-0060 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 Petition Response Letter from FDA CDER to Mr Raubicheck on behalf of Pharmachem Laboratories Inc. Other Letter(s) 2020-05-26T04:00:00Z 2020 5 2020-05-26T04:00:00Z   2020-05-26T18:32:39Z   0 0 09000064846af5d2
FDA-2000-P-0133-0058 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 Petition Response Letter from FDA CDER to Anthony L. Young on behalf of Pharmavite Other Letter(s) 2020-05-26T04:00:00Z 2020 5 2020-05-26T04:00:00Z   2020-05-26T18:13:31Z   0 0 09000064846af0c3
FDA-2000-P-0133-0059 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 Petition Response Letter from FDA CDER to Ms. Guggenheim on behalf of Cargill Other Letter(s) 2020-05-26T04:00:00Z 2020 5 2020-05-26T04:00:00Z   2020-05-26T18:21:35Z   0 0 09000064846aecb6
FDA-2000-P-0133-0057 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 Petition Response Letter from FDA CDER to Anthony L. Young on behalf of Botanical Laboratories, Inc. Other Letter(s) 2020-05-26T04:00:00Z 2020 5 2020-05-26T04:00:00Z   2020-05-26T17:53:27Z   0 0 09000064846aeace
FDA-2000-P-0133-0054 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 Health Claims: Phytosterols and Risk of Coronary Heart Disease Notice General Notice 2012-02-23T05:00:00Z 2012 2 2012-02-23T05:00:00Z 2012-04-24T03:59:59Z 2012-04-24T12:01:32Z 2012-03940 0 0 0900006480fbdb92
FDA-2000-P-0133-0050 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 Food Labeling; Health Claim; Phytosterols and Risk of Coronary Heart Disease; Reopening of the Comment Period Proposed Rule Notice of Proposed Rulemaking (NPRM) 2011-08-11T04:00:00Z 2011 8 2011-08-11T04:00:00Z 2011-10-26T03:59:59Z 2011-08-11T14:44:41Z 2011-20406 0 0 0900006480eddb33
FDA-2000-P-0133-0047 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 List of References 31-69 - [Food Labeling; Health Claim; Phytosterols and Risk of Coronary Heart Disease] Supporting & Related Material BKG- Background Material (internal references) 2011-03-25T04:00:00Z 2011 3     2011-03-25T21:03:47Z   0 0 0900006480befe54
FDA-2000-P-0133-0046 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 Acknowledgement Letter to Botanical Laboratories, Inc. (Kleinfeld Kaplan and Becker, LLP) Other ACK-Acknowledgement Letter 2011-03-24T04:00:00Z 2011 3 2011-03-24T04:00:00Z   2013-07-27T23:48:11Z   0 0 0900006480c0df46
FDA-2000-P-0133-0045 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 Botanical Laboratories, Inc. (Kleinfeld Kaplan and Becker, LLP) - Petition for Stay Other PSA-Petition for Stay 2011-03-24T04:00:00Z 2011 3 2011-03-24T04:00:00Z   2013-08-11T03:13:44Z   0 0 0900006480c0ba3b
FDA-2000-P-0133-0043 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 Exhibit D - "Kevin C. Maki, Ph.D. - Curriculum Vitae" - [Pharmavite LLC (Kleinfeld, Kaplan and Becker, LLP) - Citizen Petition] re FDA-2000-P-0133-0040 Supporting & Related Material CP-Citizen Petition (Supporting & Related Materials) 2011-03-04T05:00:00Z 2011 3     2011-03-04T23:33:59Z   0 0 0900006480c0111d
FDA-2000-P-0133-0040 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 Pharmavite LLC (Kleinfeld, Kaplan and Becker, LLP) - Citizen Petition Other CP-Citizen Petition 2011-03-04T05:00:00Z 2011 3 2011-03-04T05:00:00Z   2024-11-07T22:28:35Z   1 0 0900006480bfae26
FDA-2000-P-0133-0044 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 Acknowledgement Letter to Pharmavite LLC (Kleinfeld, Kaplan and Becker, LLP) Other ACK-Acknowledgement Letter 2011-03-04T05:00:00Z 2011 3 2011-03-04T05:00:00Z   2013-07-27T23:46:13Z   0 0 0900006480bfae28
FDA-2000-P-0133-0041 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 Exhibit A - "Container and Carton Label for Nature Made® Cholestoff®" - [Pharmavite LLC (Kleinfeld, Kaplan and Becker, LLP) - Citizen Petition] re FDA-2000-P-0133-0040 Supporting & Related Material CP-Citizen Petition (Supporting & Related Materials) 2011-03-04T05:00:00Z 2011 3     2011-03-04T23:33:56Z   0 0 0900006480c0084b
FDA-2000-P-0133-0042 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 Exhibit C - "Maki, et al., A Plant Sterol/Stanol Supplement in Tablet Form Lowers LDL and Non-HDL Cholesterol in Men and Woman with Primary Hypercholesterolemia (Poster)" - [Pharmavite LLC (Kleinfeld, Kaplan and Becker, LLP) - Citizen Petition] re FDA-2000-P-0133-0040 Supporting & Related Material CP-Citizen Petition (Supporting & Related Materials) 2011-03-04T05:00:00Z 2011 3     2011-03-04T23:33:57Z   0 0 0900006480c0084d
FDA-2000-P-0133-0038 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 Exhibit D - "Kevin C. Maki, Ph.D. - Curriculum Vitae" - [Pharmavite LLC - Petition for Stay of Action] re FDA-2000-P-0133-0035 Supporting & Related Material PSA- Petition for Stay (Supporting and Related Material) 2011-03-02T05:00:00Z 2011 3     2011-03-02T20:23:58Z   0 0 0900006480bfd1d7
FDA-2000-P-0133-0035 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 Pharmavite LLC (Kleinfeld, Kaplan and Becker, LLP) - Petition for Stay of Action Other PSA-Petition for Stay 2011-03-02T05:00:00Z 2011 3 2011-03-02T05:00:00Z   2013-08-11T01:40:09Z   0 0 0900006480bfa3f2
FDA-2000-P-0133-0037 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 Exhibit C - "Maki, et al., A Plant Sterol/Stanol Supplement in Tablet Form Lowers LDL and Non-HDL Cholesterol in Men and Woman with Primary Hypercholesterolemia (Poster)" - [Pharmavite LLC - Petition for Stay of Action] re FDA-2000-P-0133-0035 Supporting & Related Material PSA- Petition for Stay (Supporting and Related Material) 2011-03-02T05:00:00Z 2011 3     2011-03-02T20:24:25Z   0 0 0900006480bfa43b
FDA-2000-P-0133-0039 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 Acknowledgement Letter to Pharmavite LLC (Kleinfeld, Kaplan and Becker, LLP) Other ACK-Acknowledgement Letter 2011-03-02T05:00:00Z 2011 3 2011-03-02T05:00:00Z   2013-08-11T01:40:09Z   0 0 0900006480bfa423
FDA-2000-P-0133-0036 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 Exhibit A - "Container and Carton Label for Nature Made® Cholestoff®" - [Pharmavite LLC - Petition for Stay of Action] re FDA-2000-P-0133-0035 Supporting & Related Material PSA- Petition for Stay (Supporting and Related Material) 2011-03-02T05:00:00Z 2011 3     2011-03-02T20:24:48Z   0 0 0900006480bfa428
FDA-2000-P-0133-0028 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 Reference - "Letter of Enforcement Discretion From FDA to Cargill Health & Food Technologies" - [Health Claim; Phytosterols and Risk of Coronary Heart Disease] re FDA-2000-P-0133-0025 Supporting & Related Material REF-Reference (internal unless indicated) 2011-02-28T05:00:00Z 2011 2     2011-02-28T21:01:53Z   0 0 0900006480bf13be
FDA-2000-P-0133-0029 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 Attachment 4 - "On Nutrition and Health Claims Made on Food" - [Innoceutics bvba-llC University of Ghent - Comment] re FDA-FDA-2000-P-0133-0027 Supporting & Related Material C-Comment (Supporting and Related Material) 2011-02-28T05:00:00Z 2011 2     2011-02-28T22:02:59Z   0 0 0900006480bfad82
FDA-2000-P-0133-0030 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 Attachment 5 - "On the Authorisation of Certain Health Claims Made on Food and Referring to the Reduction of Disease Risk an to Children's Development and Health " - [Innoceutics bvba-llC University of Ghent - Comment] re FDA-2000-P-0133-0027 Supporting & Related Material C-Comment (Supporting and Related Material) 2011-02-28T05:00:00Z 2011 2     2011-02-28T22:04:12Z   0 0 0900006480bfad83
FDA-2000-P-0133-0031 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 Attachment 6 - "Amending Regulation (EC) No. 983/2009 on the Authorisation and Refusal of Authorisation of Certain Health Claims Made on Food and Referring to the Reduction of Disease Risk and to Children's Development and Health" - [Innoceutics bvba-llC University of Ghent - Comment] re FDA-2000-P-0133-0027 Supporting & Related Material C-Comment (Supporting and Related Material) 2011-02-28T05:00:00Z 2011 2     2011-02-28T22:05:12Z   0 0 0900006480bfad84
FDA-2000-P-0133-0026 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 Reference - "Letter of Enforcement Discretion From FDA to Cargill Health & Food Technologies, February 14, 2003" - [Extension of Enforcement Discretion: Health Claim, Phytosterols and Risk of Coronary Heart Disease] Supporting & Related Material BKG-Background Material 2011-02-18T05:00:00Z 2011 2     2011-02-18T23:19:29Z   0 0 0900006480bf251f
FDA-2000-P-0133-0025 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 Health Claim; Phytosterols and Risk of Coronary Heart Disease Proposed Rule NEC-Notice of Extension 2011-02-18T05:00:00Z 2011 2 2011-02-18T05:00:00Z 2011-04-20T03:59:59Z 2011-02-28T20:59:23Z 2011-3678 0 0 0900006480bf251c
FDA-2000-P-0133-0023 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 Venable LLP - Request for Extension Comment Due Date Other EXT-Request for Extension Comment Due Date 2011-02-15T05:00:00Z 2011 2 2011-02-15T05:00:00Z   2013-07-27T23:45:23Z   0 0 0900006480befd94
FDA-2000-P-0133-0022 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 Venable, LLP - Request for Extension of Comment Due Date Other EXT-Request for Extension Comment Due Date 2011-02-14T05:00:00Z 2011 2 2010-12-08T05:00:00Z 2011-02-12T04:59:59Z 2013-07-27T23:44:52Z   0 0 0900006480bec04f
FDA-2000-P-0133-0019 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 Fommer Lawrence & Haug LLP (Pharmachem Laboratories, Inc.) - Petition for Stay Other PSA-Petition for Stay 2011-02-01T05:00:00Z 2011 2 2011-02-01T05:00:00Z   2013-08-11T01:39:31Z   0 0 0900006480bd6ec6
FDA-2000-P-0133-0020 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 Acknowledgement Letter to Fommer Lawrence & Haug LLP (Pharmachem Laboratories, Inc.) Other ACK-Acknowledgement Letter 2011-02-01T05:00:00Z 2011 2 2011-02-01T05:00:00Z   2013-07-27T23:43:59Z   0 0 0900006480bd6f6b
FDA-2000-P-0133-0018 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 Acknowledgement Letter to Covington & Burling (Cargill Inc.) Other ACK-Acknowledgement Letter 2011-01-10T05:00:00Z 2011 1 2011-01-10T05:00:00Z   2013-07-27T23:42:02Z   0 0 0900006480bc81d6
FDA-2000-P-0133-0017 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 Covington & Burling (Cargill Inc.) - Petition for Stay of Action Other PSA-Petition for Stay 2011-01-10T05:00:00Z 2011 1 2011-01-10T05:00:00Z   2024-11-12T04:58:05Z   1 0 0900006480bc81d4
FDA-2000-P-0133-0016 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 Council for Responsible Nutrition - Letter Other LET-Letter 2011-01-10T05:00:00Z 2011 1 2011-01-10T05:00:00Z   2013-07-27T23:42:02Z   0 0 0900006480bc81d2
FDA-2000-P-0133-0015 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 Tab 20 - "FDA/CFSAN, New Dietary Ingredient Report 77 & Tall Oil Phytosterols (Ingredient of Reducol)" - [Food Labeling; Health Claim; Phytosterols and Risk of Coronary Heart Disease] Supporting & Related Material BKG- Background Material (internal references) 2010-12-15T05:00:00Z 2010 12     2010-12-15T23:41:58Z   0 0 0900006480bb7ea7
FDA-2000-P-0133-0014 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 Tab 19 - "FDA/CFSAN, New Dietary Ingredient Report 77 & Plant Stanol Fatty Acid Esters" - [Food Labeling; Health Claim; Phytosterols and Risk of Coronary Heart Disease] Supporting & Related Material BKG- Background Material (internal references) 2010-12-15T05:00:00Z 2010 12     2010-12-15T23:32:15Z   0 0 0900006480bb7ea5
FDA-2000-P-0133-0009 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 EXT2 - Extension Letter Sent from Nancy L. Schnell, Deputy General Counsel, Marketing & Regulatory for Unilever United States, Inc. to Dr. Kathleen Ellwood Granting An Extension of the Health Claim Petition to Amend 21CFR101.83 Phytosterols & Risk of Heart Disease To December 16, 2009 - [Food Labeling; Health Claim; Phytosterols and Risk of Coronary Heart Disease] Supporting & Related Material BKG- Background Material (internal references) 2010-12-13T05:00:00Z 2010 12     2011-02-15T22:05:05Z   0 0 0900006480bb2453
FDA-2000-P-0133-0007 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 List of References - [Food Labeling; Health Claim; Phytosterols and Risk of Coronary Heart Disease] - Background Material Supporting & Related Material BKG- Background Material (internal references) 2010-12-13T05:00:00Z 2010 12     2010-12-14T02:58:04Z   0 0 0900006480bb241a
FDA-2000-P-0133-0008 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 EXT1 - Extension Letter Sent From Nancy L. Schnell, Deputy General Counsel, Marketing & Regulatory for Unilever United States, Inc. to Dr. Kathleen Ellwood Granting An Extension of the Health Claim Petition To Amend 21CFR101.83 Phytosterols & Risk of Heart Disease to September 16, 2009 - [Food Labeling; Health Claim; Phytosterols and Risk of Coronary Heart Disease] Supporting & Related Material BKG- Background Material (internal references) 2010-12-13T05:00:00Z 2010 12     2011-02-15T22:04:36Z   0 0 0900006480bb2420
FDA-2000-P-0133-0010 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 EXT3 - Extension Letter Sent From Nancy L. Schnell, Deputy General Counsel, Marketing & Regulatory for Unilever United States, Inc. to Ms. Blakeley Denkinger Granting An Extension for the Health Claim Petition to Amend 21CFR101.83 Phytosterols & Risk of Heart Disease to December 14, 2010 - [Food Labeling; Health Claim; Phytosterols and Risk of Coronary Heart Disease] Supporting & Related Material BKG- Background Material (internal references) 2010-12-13T05:00:00Z 2010 12     2011-02-15T22:05:42Z   0 0 0900006480bb2469
FDA-2000-P-0133-0013 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 Tab 4 - "Hallikainen, et al., - Short-Term LDL Cholesterol-Lowering Efficacy on Plants Sterol Esters" - [Food Labeling; Health Claim; Phytosterols and Risk of Coronary Heart Disease] Supporting & Related Material BKG- Background Material (internal references) 2010-12-13T05:00:00Z 2010 12     2010-12-14T02:58:13Z   0 0 0900006480bb54e6
FDA-2000-P-0133-0011 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 Tab 2 - FDA/CFSAN -"Guidance for Industry: Evidence-Based Review System for the Scientific Evaluation of Health Claims". January, 2009" - [Food Labeling; Health Claim; Phytosterols and Risk of Coronary Heart Disease] Supporting & Related Material BKG- Background Material (internal references) 2010-12-13T05:00:00Z 2010 12     2011-02-15T22:06:58Z   0 0 0900006480bb54e2
FDA-2000-P-0133-0012 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 Tab 3 - NIH - "3rd Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation & Treatment of High Blood Pressure in Adults (Adult Treatment Panel III), Executive Summary, may 2001" - [Food Labeling; Health Claim; Phytosterols and Risk of Coronary Heart Disease] Supporting & Related Material BKG- Background Material (internal references) 2010-12-13T05:00:00Z 2010 12     2010-12-14T02:58:12Z   0 0 0900006480bb54e4
FDA-2000-P-0133-0006 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 Food Labeling: Health Claim; Phytosterols and Risk of Coronary Heart Disease Proposed Rule NPR-Notice of Proposed Rule-Making 2010-12-08T05:00:00Z 2010 12 2010-12-08T05:00:00Z 2011-02-12T04:59:59Z 2010-12-08T19:18:27Z   0 0 0900006480bb1ba0
FDA-2000-P-0133-0005 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 Meeting on Smart Balance and Coronary Heart Disease Other MM-Memorandum of Meeting 2003-11-12T05:00:00Z 2003 11     2008-04-25T01:16:04Z   0 0 09000064804cfda1
FDA-2000-P-0133-0004 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 FDA Notice NEC-Notice of Extension 2001-10-12T04:00:00Z 2001 10 2001-10-12T04:00:00Z 2001-11-20T04:59:59Z 2008-04-25T01:16:05Z   0 0 09000064804cfd51
FDA-2000-P-0133-0003 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 FDA Notice NIR-Notice of Interim Rule 2000-09-14T04:00:00Z 2000 9 2000-09-14T04:00:00Z 2000-11-23T04:59:59Z 2008-04-25T01:16:05Z   0 0 09000064804cfd10
FDA-2000-P-0133-0002 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 FDA Notice NIR-Notice of Interim Rule 2000-09-14T04:00:00Z 2000 9 2000-09-14T04:00:00Z 2000-11-23T04:59:59Z 2008-04-25T01:16:04Z   0 0 09000064804cfd0b
FDA-2000-P-0133-0001 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 FDA Notice NIR-Notice of Interim Rule 2000-09-14T04:00:00Z 2000 9 2000-09-14T04:00:00Z 2000-11-23T04:59:59Z 2008-04-25T01:16:04Z   0 0 09000064804cfc48

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
Powered by Datasette · Queries took 52.792ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API